论文部分内容阅读
目的观察普外科2型糖尿病患者围手术期胰岛素泵治疗的疗效观察。方法将62例拟行手术的2型糖尿病患者分为胰岛素泵持续皮下注射组(CSII组),胰岛素多次皮下注射组(MDII组)控制围手术期血糖。比较两组患者术前及术后血糖水平、血糖达标时间、术后并发症。结果两组均可有效降低血糖,控制在手术标准中,而CSII组胰岛素用量及血糖达标时间明显少于MDII组,CSII组低血糖发生率明显低于MDII组。但两组均无严重低血糖事件。结论在2型糖尿病患者为手术期中应用胰岛素泵治疗降糖效果显著,安全性高,可缩短住院时间。
Objective To observe the curative effect of perioperative insulin pump in type 2 diabetes patients with general surgery. Methods Sixty-two patients with type 2 diabetes undergoing surgery were divided into continuous subcutaneous injection of insulin pump (CSII group) and multiple subcutaneous injection of insulin (MDII group) to control perioperative blood glucose. Preoperative and postoperative blood glucose levels, blood glucose compliance time and postoperative complications were compared between the two groups. Results Both groups were effective in lowering blood glucose and controlling the operation standard. However, the insulin dosage and blood glucose level in CSII group were significantly less than those in MDII group. The incidence of hypoglycemia in CSII group was significantly lower than that in MDII group. However, there was no severe hypoglycemic event in both groups. Conclusion In patients with type 2 diabetes during the operation of the application of insulin pump treatment of hypoglycemic effect was significant, safe, can shorten the length of stay.